Question 1

What routes can Sirolimus be administered by?

Accepted Answer

Available routes: PO.

Question 2

Is Sirolimus a controlled substance?

Accepted Answer

Sirolimus is not federally scheduled in the US. Controlled-drug status differs by country — verify your local rules.

Question 3

What are the warnings or contraindications for Sirolimus?

Accepted Answer

Immunosuppression increases infection risk. Monitor CBC, liver, renal, and lipids. Drug interactions with CYP3A4 inhibitors. Limited veterinary data outside oncology research.

Question 4

What are the side effects of Sirolimus?

Accepted Answer

Reported side effects, adverse reactions, and contraindications for Sirolimus: Immunosuppression increases infection risk. Monitor CBC, liver, renal, and lipids. Drug interactions with CYP3A4 inhibitors. Limited veterinary data outside oncology research.

Question 5

How does Sirolimus work?

Accepted Answer

Inhibits mammalian target of rapamycin (mTOR), blocking T-cell proliferation driven by IL-2. Also has antiproliferative effects on smooth muscle and tumor cells.

Sirolimus

Drug Class

Routes

Mechanism of Action

Side effects & warnings

Upgrade for Full Details